Iliyasu Datti Gwarzo
Iliyasu Datti Gwarzo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Abdulateef Salisu
Solina Centre for International Development and Research (SCIDaR), Abuja 904101, Nigeria
1 shared publication - Adejoke Christiana Ajibulu
Solina Centre for International Development and Research (SCIDaR), Abuja 904101, Nigeria
1 shared publication - Chioma Edith Ijah
Solina Centre for International Development and Research (SCIDaR), Abuja 904101, Nigeria
1 shared publication - Demilade Osoteku
Solina Centre for International Development and Research (SCIDaR), Abuja 904101, Nigeria
1 shared publication - Eric Aigbogun
Solina Centre for International Development and Research (SCIDaR), Nigeria
1 shared publication - Ernest Ezeogu
Solina Centre for International Development and Research (SCIDaR), Abuja 904101, Nigeria
1 shared publication
Latest Publications
- Open Access
Nutritional Status Transitions in Children Aged 6–59 Months and Caregiver Perspectives Following a Community-Based Digital MUAC Screening and Counselling Campaign in Kaduna State, Nigeria: A Mixed-Methods Study
Background: Acute malnutrition affects 45 million children under five globally. Nigeria has Africa’s highest number of malnourished children, and wasting in Kaduna State has increased from 4.8% to 5.9%. Evidence on within-child nutritional transitions following community-based screening and counselling, and caregivers’ perspectives on factors influencing these changes, remains limited. This study examined nutritional changes between two MUAC assessments and caregivers’ perceived influences, without evaluating campaign effectiveness. Methods: A mixed-methods study was conducted in Kudan Local Government Area (LGA), Kaduna State, combining a retrospective longitudinal analysis of routinely collected MUAC data from 37,455 children aged 6–59 months with paired measurements at baseline and six-month follow-up (December 2024 to June 2025, the first six months of a 12-month campaign) with 36 in-depth interviews with caregivers. Nutritional transition (improved, static or declined) was defined using MUAC thresholds (well-nourished ≥12.5 cm, moderate acute malnutrition [MAM] 11.5 to t-tests. Interviews were analyzed thematically. Results: At baseline, 95.3% of children were well-nourished, 4.1% had moderate acute malnutrition (MAM) and 0.6% had severe acute malnutrition (SAM). At follow-up, 98.9% were well-nourished, 1.1% had MAM and 0.06% had SAM (net MAM reduction 73.9%, SAM reduction 90.6%). In total, 94.9% of children were static, 4.3% improved (all from MAM or SAM to well-nourished; 92.7% of the 1756 children malnourished at baseline) and 0.8% declined. Mean MUAC increased by 0.26 cm (p < 0.001), an increase that includes normal age-related growth. Mean MUAC gain was greater among children aged 6 to 23 months than among those aged 24 to 59 months (0.29 cm vs. 0.23 cm; p < 0.001). A total of 3704 children (9.0%) with a baseline measurement were lost to follow-up; among malnourished children, 128 of 1756 (7.3%) were not re-measured. Caregivers reported improved feeding and hygiene practices but identified household food insecurity, rising food prices and transport costs as persistent barriers. Conclusions: Most children remained in the same nutritional category, while most children malnourished at baseline were well-nourished at follow-up. Without a comparison group, observed changes cannot be attributed to the campaign. Loss to follow-up may also limit interpretation. Evaluating effectiveness requires a controlled design and systematic tracking of children lost to follow-up.
Open AccessNutritional Status Transitions in Children Aged 6–59 Months and Caregiver Perspectives Following a Community-Based Digital MUAC Screening and Counselling Campaign in Kaduna State, Nigeria: A Mixed-Methods Study
Background: Acute malnutrition affects 45 million children under five globally. Nigeria has Africa’s highest number of malnourished children, and wasting in Kaduna State has increased from 4.8% to 5.9%. Evidence on within-child nutritional transitions following community-based screening and counselling, and caregivers’ perspectives on factors influencing these changes, remains limited. This study examined nutritional changes between two MUAC assessments and caregivers’ perceived influences, without evaluating campaign effectiveness. Methods: A mixed-methods study was conducted in Kudan Local Government Area (LGA), Kaduna State, combining a retrospective longitudinal analysis of routinely collected MUAC data from 37,455 children aged 6–59 months with paired measurements at baseline and six-month follow-up (December 2024 to June 2025, the first six months of a 12-month campaign) with 36 in-depth interviews with caregivers. Nutritional transition (improved, static or declined) was defined using MUAC thresholds (well-nourished ≥12.5 cm, moderate acute malnutrition [MAM] 11.5 to t-tests. Interviews were analyzed thematically. Results: At baseline, 95.3% of children were well-nourished, 4.1% had moderate acute malnutrition (MAM) and 0.6% had severe acute malnutrition (SAM). At follow-up, 98.9% were well-nourished, 1.1% had MAM and 0.06% had SAM (net MAM reduction 73.9%, SAM reduction 90.6%). In total, 94.9% of children were static, 4.3% improved (all from MAM or SAM to well-nourished; 92.7% of the 1756 children malnourished at baseline) and 0.8% declined. Mean MUAC increased by 0.26 cm (p < 0.001), an increase that includes normal age-related growth. Mean MUAC gain was greater among children aged 6 to 23 months than among those aged 24 to 59 months (0.29 cm vs. 0.23 cm; p < 0.001). A total of 3704 children (9.0%) with a baseline measurement were lost to follow-up; among malnourished children, 128 of 1756 (7.3%) were not re-measured. Caregivers reported improved feeding and hygiene practices but identified household food insecurity, rising food prices and transport costs as persistent barriers. Conclusions: Most children remained in the same nutritional category, while most children malnourished at baseline were well-nourished at follow-up. Without a comparison group, observed changes cannot be attributed to the campaign. Loss to follow-up may also limit interpretation. Evaluating effectiveness requires a controlled design and systematic tracking of children lost to follow-up.
- 13 June 2025
- Published by Penerbit UTM Press in Jurnal Teknologi (Sciences & Engineering)
- Vol. 87 (4) , 749-763
Hibiscus sabdariffa Linn. WATER-ETHANOL EXTRACT NANOEMULSION FOR RETARDING GLUCOSE ABSORPTION
Diabetes is the one of the prevalent non-communicable diseases, affecting millions across the globe. Conversely, conventional therapy involving blood glucose-lowering medications and insulin injections may lead to drug resistance or side effects because of the one-drug mechanism. Hibiscus sabdariffa Linn. (HSL) has the potential to maintain blood glucose levels and can be used along with the conventional treatment as an alternative approach. The phenolic components of HSL extract are very sensitive to environmental factors during processing and storage, resulting in low bioavailability and activity. Formulating the extract into a nanoemulsion extract is one technique to solve this problem. The best HSL water-in-oil nanoemulsion was achieved using 7% polyglycerol polyricinoleate (PGPR) surfactant, medium chain-length triglyceride (MCT): corn oil (1:1) which was subjected to different stability testing such as mean droplet size, polydispersity index, zeta potential, coalescent and Ostwald ripening. The in-vitro glucose release study using a dialysis tube revealed that HSL decreased the glucose diffusion to the outside solution (NaCl: 0.15M, 10 mL) by 44.12% after 24 hours. In short, the formulated HSL successfully resulted in the retarding of the release of glucose, conveying its potential use as a natural supplement for diabetic treatments.
- 13 June 2025
- Published by Penerbit UTM Press in Jurnal Teknologi (Sciences & Engineering)
- Vol. 87 (4) , 749-763
Hibiscus sabdariffa Linn. WATER-ETHANOL EXTRACT NANOEMULSION FOR RETARDING GLUCOSE ABSORPTION
Diabetes is the one of the prevalent non-communicable diseases, affecting millions across the globe. Conversely, conventional therapy involving blood glucose-lowering medications and insulin injections may lead to drug resistance or side effects because of the one-drug mechanism. Hibiscus sabdariffa Linn. (HSL) has the potential to maintain blood glucose levels and can be used along with the conventional treatment as an alternative approach. The phenolic components of HSL extract are very sensitive to environmental factors during processing and storage, resulting in low bioavailability and activity. Formulating the extract into a nanoemulsion extract is one technique to solve this problem. The best HSL water-in-oil nanoemulsion was achieved using 7% polyglycerol polyricinoleate (PGPR) surfactant, medium chain-length triglyceride (MCT): corn oil (1:1) which was subjected to different stability testing such as mean droplet size, polydispersity index, zeta potential, coalescent and Ostwald ripening. The in-vitro glucose release study using a dialysis tube revealed that HSL decreased the glucose diffusion to the outside solution (NaCl: 0.15M, 10 mL) by 44.12% after 24 hours. In short, the formulated HSL successfully resulted in the retarding of the release of glucose, conveying its potential use as a natural supplement for diabetic treatments.
- 24 January 2022
- Published by Lujosh Ventures Limited
- Vol. 1 (1) , 9-36
Molecular Docking Analysis of Azadirachta Indica Phytocompounds against Androgen Receptor Protein for the Treatment of Prostate Cancer
In affluent countries, prostate cancer (PCa), one of the leading causes of male death, continues to be a serious medical burden. Androgen stimulates growth and advancement primarily through the androgen receptor. PCa is thought to include some molecular pathways in its growth and progression. In this work, several bioactive components of the neem plant (Azadirachta indica) were studied using the molecular docking analysis to identify and create novel medicines or inhibitors that can target androgen receptors for the treatment of prostate cancer. Azadirachta indica has been demonstrated to have therapeutic potential in the treatment of cancer. We investigated the molecular interactions of 30 bioactive chemicals in Azadirachta indica leaves against prostate cancer in this work. Androgen receptor protein is implicated in the genesis and progression of prostate cancer. A screening technique was used to perform molecular docking. PyMOL v 1.1r1 and Discovery studio 2020 were used to execute auto dock vina of the PyRx v 0.8 docking software and visualization, respectively. The SwissADME online software was used to assess the hit compounds’ physicochemical attributes. The selected ligands demonstrated good inhibitory action in docking tests with the target proteins. The binding affinities range from -6.0 to -8.5 (kcal/mol) in the docking results of the selected hits, which is greater than the typical medicines employed. Among the identified ligands, Etofenprox had the greatest binding score with the target protein, whereas 4-hydroxystyrene, 3-Methylbenzaldehyde, and Limonene had the lowest binding energy with the target protein.
- 24 January 2022
- Published by Lujosh Ventures Limited
- Vol. 1 (1) , 9-36
Molecular Docking Analysis of Azadirachta Indica Phytocompounds against Androgen Receptor Protein for the Treatment of Prostate Cancer
In affluent countries, prostate cancer (PCa), one of the leading causes of male death, continues to be a serious medical burden. Androgen stimulates growth and advancement primarily through the androgen receptor. PCa is thought to include some molecular pathways in its growth and progression. In this work, several bioactive components of the neem plant (Azadirachta indica) were studied using the molecular docking analysis to identify and create novel medicines or inhibitors that can target androgen receptors for the treatment of prostate cancer. Azadirachta indica has been demonstrated to have therapeutic potential in the treatment of cancer. We investigated the molecular interactions of 30 bioactive chemicals in Azadirachta indica leaves against prostate cancer in this work. Androgen receptor protein is implicated in the genesis and progression of prostate cancer. A screening technique was used to perform molecular docking. PyMOL v 1.1r1 and Discovery studio 2020 were used to execute auto dock vina of the PyRx v 0.8 docking software and visualization, respectively. The SwissADME online software was used to assess the hit compounds’ physicochemical attributes. The selected ligands demonstrated good inhibitory action in docking tests with the target proteins. The binding affinities range from -6.0 to -8.5 (kcal/mol) in the docking results of the selected hits, which is greater than the typical medicines employed. Among the identified ligands, Etofenprox had the greatest binding score with the target protein, whereas 4-hydroxystyrene, 3-Methylbenzaldehyde, and Limonene had the lowest binding energy with the target protein.